What investment strategy does EKA Ventures focus on?

EKA Ventures focuses on VC strategies in the private equity space.

How many portfolio companies does EKA Ventures have?

EKA Ventures has 24 active portfolio companies and 1 completed exit and 2 funds tracked on GP Intel.

Where is EKA Ventures headquartered?

EKA Ventures is headquartered in London, United Kingdom.

What is EKA Ventures's assets under management?

EKA Ventures manages approximately €184M in assets under management.

When was EKA Ventures founded?

EKA Ventures was founded in 2018.

What sectors does EKA Ventures invest in?

EKA Ventures invests across Consumer, Healthcare, TMT.

What are EKA Ventures's recent exits?

Recent realized exits by EKA Ventures include: Runna (2025) to Strava.

Home/GPs/EKA Ventures

DetailCard

EKA Ventures

London, United Kingdom·Founded 2018·

Venture Capital

·ekavc.com

EKA Ventures is a London-based early-stage impact venture capital firm founded in 2018 by Jon Coker and Camilla Dolan, investing at seed and Series A in UK consumer-technology companies across sustainable consumption, consumer healthcare and the inclusive economy. It raised a GBP 68 million Fund I (final close 2021) and a GBP 80 million (USD 107 million) Fund II (2026), bringing total assets under management to USD 200 million and making it the UK's largest early-stage impact VC. Eka Ventures LLP is authorised and regulated by the UK Financial Conduct Authority under firm reference number 848631.

AUM

€184M

Funds

vintages 2021–2026

Portfolio

Exits

EKA Ventures is a London venture capital firm with €184M AUM, 24 active companies and 1 exit.

SectorsConsumer Healthcare TMT

Key takeaways

·Top sector focus: HealthTech (28% of portfolio).
·Fund cadence: ~5Y between vintages · last raise 2026.

Sector breakdown

25 companies

HealthTech

7 · 28%

ClimateTech

4 · 16%

Consumer

3 · 12%

Biotech

2 · 8%

Logistics

2 · 8%

MedTech

2 · 8%

Fintech

1 · 4%

EdTech

1 · 4%

Key facts

HQLondon, United Kingdom

Founded2018

Employees6+

Websiteekavc.com

Recent exits

EKA Ventures sold Runna to Strava in 2025 after 3 years.

Partners

Jon CokerGeneral Partner

Camilla DolanGeneral Partner

Coverage notes

2 funds tracked, 25 portfolio companies (24 active · 1 realized). Verified weekly from public filings and deal announcements.

Investment team

Senior partners. Hand-checked from public filings and the firm's own site.

Jon Coker

General Partner · Co-founder

Camilla Dolan

General Partner · Co-founder

Funds & portfolio

Every fund EKA Ventures has raised, with its portfolio companies. Hand-checked from public filings.

2 funds

Fund

Strategy

Vintage

Size

Assets

Exits

Eka Ventures Fund II

Impact2026€80M7 assets

Impact

2026 · 0yr

€80M

–

Unrealized

7 held

Company	Entry
Chune HealthTech · UK	2026
Conveyd Fintech · UK	2025
Cyclana Bio Biotech · UK	2025
Ditto Daily Consumer · UK	2025
Hesta Health HealthTech · UK	2025
Medly AI EdTech · UK	2025
Minml ClimateTech · UK	2026

Eka Ventures Fund I

Impact2021€80M17 assets1 exits

Impact

2021 · 5yr

€80M

Unrealized

17 held

Company	Entry
32Co HealthTech · UK	2024
Airhive ClimateTech · UK	2024
Axle ClimateTech · UK	2023
Byway Hospitality · UK	2021
Flok Health HealthTech · UK	2022
Foresight Data Machines AI/ML · UK	2022
Hived Logistics · UK	2021
Hylo Consumer · UK	2022
Isla HealthTech · UK	2023
Jude HealthTech · UK	2022
MakeSense MedTech · UK	2024
Oxford Cancer Analytics Biotech · UK	2022
Paired Consumer · UK	2021
Sourceful Logistics · UK	2021
Sustained ClimateTech · UK	2021
Urban Jungle InsurTech · UK	2022
XRlabs MedTech · UK	2024

Realized

1 exit

Company	Entry	Exit	Type	Buyer	MOIC
Runna HealthTech · UK	2022	2025	Trade Sale	Strava	–

About EKA Ventures

EKA Ventures is the UK's largest early-stage impact venture capital firm with approximately $200 million of total assets across Fund I and Fund II as of December 2024 (Fund II $107 million / £80 million closed late 2024 / early 2025), headquartered in London. The firm was founded in 2018 by Jon Huggins and Camilla Richards and operates as a partner-owned independent FCA-regulated (FRN 848631) B Corp certified VC.

Investment thesis

EKA Ventures deploys capital through two flagship funds (Fund I 2020, Fund II 2024-2025), targeting pre-seed and seed-stage UK impact venture capital leading or co-leading 90% of deals with approximately $2 million average initial cheque across consumer-led mega trends spanning Life, Health and Sustainability. Sector focus spans consumer health and femtech, climate tech, sustainable supply chains, preventative healthcare, consumer goods and fintech and legaltech. Fund II plans up to 30 UK startups. Geographic deployment is UK-focused. The founder-aligned thought partner model provides strategic guidance beyond capital.

Recent activity

Recent realised exits include consumer health and fitness apps (Runna acquired by Strava, April 2025). Recent acquisitions include femtech and menstrual health (DITTO Daily £1.35 million pre-seed lead, August 2025) plus active deployment across Hived (last-mile logistics), Jude (urinary health), Flok Health (musculoskeletal AI) and Foresight Data Machines. The platform continues active deployment of Fund II across the UK impact thesis.

Frequently asked questions

What investment strategy does EKA Ventures focus on?: EKA Ventures focuses on VC strategies in the private equity space.
How many portfolio companies does EKA Ventures have?: EKA Ventures has 24 active portfolio companies and 1 completed exit and 2 funds tracked on GP Intel.
Where is EKA Ventures headquartered?: EKA Ventures is headquartered in London, United Kingdom.
What is EKA Ventures's assets under management?: EKA Ventures manages approximately €184M in assets under management.
When was EKA Ventures founded?: EKA Ventures was founded in 2018.
What sectors does EKA Ventures invest in?: EKA Ventures invests across Consumer, Healthcare, TMT.
What are EKA Ventures's recent exits?: Recent realized exits by EKA Ventures include: Runna (2025) to Strava.